surpris revers tavr result crush
estim drive one ew best quarter time sinc expect
continu weak cardiac procedur surpris us neutral
strong result may see rebound head expect
delay vascular procedur would continu pressur cardiac consult
seem procedur rapidli return system consequ may
mean cardiac result buy pt buy
pt buy pt look strong quarter ew tavr
growth well strength seem also surpris management
without realli abl pinpoint co suggest may benefit
strong result feel compani investor
clear grasp quarter continu lumpi hard predict even
indic underli market center adopt new market growth
ncd chang continu hold promis enough rais tavr outlook beyond
tavr mitral sale despit posit feedback pascal
question achiev full-year mitral guidanc though ramp
continu close frankli whether
realli matter long term mitral growth driver
importantli ew initi pivot trial sapien transsept mitral
replac year-end clear posit view sinc mean fim trial
must gone well mention preview expect data
could catalyst given tct confer elsewher
optimist tavr outlook combin evid consist ep pull-through
drive estim higher today share trade nearli ep forecast
signific premium feel share price price success mitral trial
ramp maintain neutral
idc btig estim compani document
million except per share amount
portfolio prune key asset advanc tavr side big news
discontinu centera end ew quest self-expand
option exit could margin posit lotu manag also
announc end develop forma tricuspid repair instead
focu make headway tricuspid program like pascal
cardioband timelin manag reiter plan initi trial
pascal fmr tricuspid regurgit late one-year data
pascal dmr unveil year tct meet
valuat maintain neutral risk page
edward rate neutral view edward well-round aortic mitral tricuspid portfolio
make competit long-term confid trans-sept mitral replac product
could closer previous estim near-term number headwind time product launch
competit entri skew optic see real urgenc share feel
share market cap price mani thing go right bake success mitral program
stabl procedur growth price
expans current tam
cut reimburs
edward major market
surgic heart valv
multipl area critic care
three import
result stock trade almost
entir thv result
adj ww thv revenu came consensu compani longer break
 vs ou tavr perform dollar manag estim tavr procedur grew high-singl digit
vs low double-digit ew growth in-lin market ou tavr procedur improv
mid-teen vs low double-digit ew perform also compar manag believ
global share stabl sequenti edward observ growth broad-bas similar improv
high low volum center manag anticip fda approv sapien sapien ultra low-risk
turn mitral report sale quarter fairli in-lin consensu sale
improv report
adj gross margin sequenti model year-over-year improv gross
margin driven currenc product mix off-set invest manufactur exclud special adjust
sg margin touch forecast dollar basi sg spend increas y/i due
higher salesforc expens growth mitral salesforc europ meanwhil adj margin
higher forecast margin increas y/i due invest thv program compani
continu expect expens ramp cours year adj ebit margin dip
sequenti lower tax rate vs forecast help ep sum adj ep higher
model
actualsbtig estimate variancethv tmtt revenu heart valv revenu million adj consign revenu revenu expens expens net dilut gross margin bpssg margin bpsr spend bpsadj ebit margin bpstax rate bpssourc btig research estim compani filingsal metric present herein non-gaap basi margin estim non-gaap basi varianc
revenu rais revenu estim princip tavr beat respect ep
trim gross margin shortfal maintain opex assumpt adj ep forecast
move
incorpor share buy-back expect gener remain strong
absenc assum cash funnel repurchas forecast y/i ep growth
edward rate neutral feel ew current market capit price lead market share
fulli penetr matur tavr market year signific mitral sale btig provid price target
neutral-r stock risk includ competit patent litig slippag product timelin chang procedur
reimburs futur devic data fda possibl multipl contraction/expans
exhibit comp tabl larg cap med-tech compani
newnewold growth incom ep growth btig research estim compani filingsntm johnsonjnjnot bdxnot scientificbsxbuy lifesciencesewneutr factset data btig estimatespr ptpricemarket cap bp/e ex-amortev/sal
edward incom revenu inc thv return y/i good gross sg other- total oper oper incom ex interest interest expens pre-tax incom tax non-gaap net non-gaap share ex marginsgross net total total total oper tax ep btig estim compani report
edward gaap revenu us thv y/i ou thv y/i tmtt y/i heart valv y/i y/i gaap net y/i non-gaap revenu us thv y/i ou thv y/i tmtt y/i heart valv y/i y/i non-gaap net y/i btig estim compani report
btig cover compani mention report
appendix analyst certif import disclosur
